The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer--a pilot study
- PMID: 11180589
- DOI: 10.1002/1099-1611(200011/12)9:6<537::aid-pon479>3.0.co;2-u
The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer--a pilot study
Abstract
Aim: To describe the short and longer-term psychological consequences of waiting for the results of mutation searching (MS) amongst those at risk of hereditary breast and ovarian cancer (HBOC).
Design: A prospective study, with measures before the offer of a mutation search, and 1 week, 6 months and 12 months afterwards.
Sample: 21 unaffected women at risk of HBOC offered MS in an affected relative at one of two UK regional genetics centres.
Outcome measures: Standardized questionnaire measures of general anxiety, general distress, distress about cancer in the family and cancer-specific worries.
Results: Mutation searches were initiated in 15 of 21 families; two received results within 12 months. For the 13 still waiting for results, levels of anxiety and distress were within normal ranges at all time-points. They reported reduced worries about cancer 6 and 12 months post-search offer compared with earlier assessments, but experienced an increase in general anxiety 12 months since the search offer. These changes over time were not found in those not waiting for the results of a mutation search.
Conclusion: The majority of women were without a result 12 months after being offered MS. Whilst these women were less worried about cancer in the 6 months after initiating the testing process, their anxiety levels increased 12 months since the offer of a mutation search. Seeing a specialist seems to reduce cancer worries. There may, however, be long-term psychological costs of offering tests that are unlikely to give results in a foreseeable future.
Similar articles
-
Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.Fam Cancer. 2005;4(2):121-6. doi: 10.1007/s10689-004-7995-y. Fam Cancer. 2005. PMID: 15951962
-
Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.J Psychosom Res. 2016 Oct;89:39-45. doi: 10.1016/j.jpsychores.2016.08.005. Epub 2016 Aug 8. J Psychosom Res. 2016. PMID: 27663109
-
Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.Fam Cancer. 2008;7(3):245-54. doi: 10.1007/s10689-008-9182-z. Epub 2008 Jan 25. Fam Cancer. 2008. PMID: 18219587
-
Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.Psychooncology. 2010 Jan;19(1):1-11. doi: 10.1002/pon.1582. Psychooncology. 2010. PMID: 19472298 Review.
-
Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer.Curr Opin Oncol. 2005 Jul;17(4):340-4. doi: 10.1097/01.cco.0000166653.15546.06. Curr Opin Oncol. 2005. PMID: 15933464 Review.
Cited by
-
Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study.BMJ Open. 2013 Mar 13;3(3):e002227. doi: 10.1136/bmjopen-2012-002227. BMJ Open. 2013. PMID: 23485718 Free PMC article.
-
Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutation.Qual Life Res. 2006 Apr;15(3):461-70. doi: 10.1007/s11136-005-3008-3. Qual Life Res. 2006. PMID: 16547785
-
Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.Fam Cancer. 2005;4(2):121-6. doi: 10.1007/s10689-004-7995-y. Fam Cancer. 2005. PMID: 15951962
-
The information and support needs of women at high risk of familial breast and ovarian cancer: how can cancer genetic services give patients what they want?Fam Cancer. 2003;2(2):119-21. doi: 10.1023/a:1025706907045. Fam Cancer. 2003. PMID: 14649669 No abstract available.
-
Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.Fam Cancer. 2005;4(2):195-206. doi: 10.1007/s10689-004-1446-7. Fam Cancer. 2005. PMID: 15951974
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical